Lund Melanoma Study Group
51 – 60 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
- Contribution to journal › Article
-
Mark
South Africa and the Surgical Diaspora-A Hub for Surgical Migration and Training
- Contribution to journal › Article
-
Mark
Factors for not performing total body skin examinations in primary care in association with teledermoscopy
- Contribution to journal › Article
-
Mark
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
- Contribution to journal › Article
-
Mark
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
- Contribution to journal › Article
-
Mark
Association of metformin use and survival in patients with cutaneous melanoma and diabetes
- Contribution to journal › Article
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
- Contribution to journal › Article
-
Mark
Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
- Contribution to journal › Article
-
Mark
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
- Contribution to journal › Article
- 2022
-
Mark
Incidence and trends of basal cell carcinoma in Sweden : A population-based registry study
- Contribution to journal › Article
